● Recruiting

A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

Condition: Metabolic Dysfunction-Associated Steatohepatitis · Non-alcoholic Fatty Liver Disease · Sponsor: GlaxoSmithKline

PhasePhase 2

Planned participants42

Who can joinAll sexes, 18 Years to 75 Years

Healthy volunteersNo

About this study

The purpose of this study is to evaluate the safety, tolerability, preliminary efficacy, and pharmacokinetics (PK) of efimosfermin in participants with metabolic dysfunction associated steatohepatitis (MASH) and compensated cirrhosis consistent with stage F4 fibrosis.

This description comes directly from the study's public registry record.

Talk to the study team

US GSK Clinical Trials Call Center · 877-379-3718 · GSKClinicalSupportHD@gsk.com

EU GSK Clinical Trials Call Center · +44 (0) 20 89904466 · GSKClinicalSupportHD@gsk.com

Always discuss trial participation with your own doctor first.

Locations (30)

GSK Investigational Site	Chandler, Arizona, United States	Recruiting
GSK Investigational Site	Mesa, Arizona, United States	Recruiting
GSK Investigational Site	Tucson, Arizona, United States	Recruiting
GSK Investigational Site	Fresno, California, United States	Recruiting
GSK Investigational Site	Lancaster, California, United States	Recruiting
GSK Investigational Site	Pasadena, California, United States	Recruiting
GSK Investigational Site	Rialto, California, United States	Recruiting
GSK Investigational Site	Santa Maria, California, United States	Recruiting
GSK Investigational Site	Miami, Florida, United States	Recruiting
GSK Investigational Site	Viera, Florida, United States	Recruiting
GSK Investigational Site	Marietta, Georgia, United States	Recruiting
GSK Investigational Site	Baltimore, Maryland, United States	Recruiting

+ 18 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06920043